U.S. markets closed
  • S&P 500

    4,241.84
    -4.60 (-0.11%)
     
  • Dow 30

    33,874.24
    -71.34 (-0.21%)
     
  • Nasdaq

    14,271.73
    +18.46 (+0.13%)
     
  • Russell 2000

    2,303.47
    +7.52 (+0.33%)
     
  • Crude Oil

    73.28
    +0.20 (+0.27%)
     
  • Gold

    1,778.70
    -4.70 (-0.26%)
     
  • Silver

    25.93
    -0.18 (-0.67%)
     
  • EUR/USD

    1.1933
    -0.0010 (-0.08%)
     
  • 10-Yr Bond

    1.4870
    +0.0150 (+1.02%)
     
  • GBP/USD

    1.3967
    +0.0020 (+0.15%)
     
  • USD/JPY

    110.9700
    +0.3350 (+0.30%)
     
  • BTC-USD

    33,288.42
    +744.12 (+2.29%)
     
  • CMC Crypto 200

    800.68
    -9.51 (-1.17%)
     
  • FTSE 100

    7,074.06
    -15.95 (-0.22%)
     
  • Nikkei 225

    28,874.89
    -9.24 (-0.03%)
     

Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes

·2 min read
Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Jazz Pharmaceuticals (NASDAQ: JAZZ) and GW Pharmaceuticals are now under the same corporate roof. The two companies announced Wednesday that Jazz's acquisition of GW has been completed. In the companies' joint press release, Jazz CEO Bruce Cozadd was quoted as saying that the closing "mark[s] a transformative milestone in creating an innovative, high-growth, global biopharma leader in neuroscience with a worldwide commercial and operational footprint."